Literature DB >> 3024797

Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.

G Chaloner-Larsson, G Contreras, J Furesz, D W Boucher, D Krepps, G R Humphreys, S M Mohanna.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3024797

Source DB:  PubMed          Journal:  Can J Public Health        ISSN： 0008-4263


× No keyword cloud information.
  5 in total

1.  Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.

Authors:  S A Rosenberg; Y Zhai; J C Yang; D J Schwartzentruber; P Hwu; F M Marincola; S L Topalian; N P Restifo; C A Seipp; J H Einhorn; B Roberts; D E White
Journal:  J Natl Cancer Inst       Date:  1998-12-16       Impact factor: 13.506

2.  Studies on the stability of a human adenovirus-rabies recombinant vaccine.

Authors:  K K Kalicharran; V S Springthorpe; S A Sattar
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

3.  Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.

Authors:  Xiangming Li; Jing Huang; Akira Kawamura; Ryota Funakoshi; Steven A Porcelli; Moriya Tsuji
Journal:  Vaccine       Date:  2017-05-05       Impact factor: 3.641

4.  Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen.

Authors:  P W Chen; M Wang; V Bronte; Y Zhai; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

5.  Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.

Authors:  M A Morsy; E L Alford; A Bett; F L Graham; C T Caskey
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.